Day Samantha E, Coletta Richard L, Kim Joon Young, Campbell Latoya E, Benjamin Tonya R, Roust Lori R, De Filippis Elena A, Dinu Valentin, Shaibi Gabriel Q, Mandarino Lawrence J, Coletta Dawn K
School of Life Sciences, Arizona State University, Tempe, AZ USA.
School for the Science of Health Care Delivery, Arizona State University, Phoenix, AZ USA.
Clin Epigenetics. 2016 Jul 18;8:77. doi: 10.1186/s13148-016-0246-x. eCollection 2016.
Obesity is a metabolic disease caused by environmental and genetic factors. However, the epigenetic mechanisms of obesity are incompletely understood. The aim of our study was to investigate the role of skeletal muscle DNA methylation in combination with transcriptomic changes in obesity.
Muscle biopsies were obtained basally from lean (n = 12; BMI = 23.4 ± 0.7 kg/m(2)) and obese (n = 10; BMI = 32.9 ± 0.7 kg/m(2)) participants in combination with euglycemic-hyperinsulinemic clamps to assess insulin sensitivity. We performed reduced representation bisulfite sequencing (RRBS) next-generation methylation and microarray analyses on DNA and RNA isolated from vastus lateralis muscle biopsies. There were 13,130 differentially methylated cytosines (DMC; uncorrected P < 0.05) that were altered in the promoter and untranslated (5' and 3'UTR) regions in the obese versus lean analysis. Microarray analysis revealed 99 probes that were significantly (corrected P < 0.05) altered. Of these, 12 genes (encompassing 22 methylation sites) demonstrated a negative relationship between gene expression and DNA methylation. Specifically, sorbin and SH3 domain containing 3 (SORBS3) which codes for the adapter protein vinexin was significantly decreased in gene expression (fold change -1.9) and had nine DMCs that were significantly increased in methylation in obesity (methylation differences ranged from 5.0 to 24.4 %). Moreover, differentially methylated region (DMR) analysis identified a region in the 5'UTR (Chr.8:22,423,530-22,423,569) of SORBS3 that was increased in methylation by 11.2 % in the obese group. The negative relationship observed between DNA methylation and gene expression for SORBS3 was validated by a site-specific sequencing approach, pyrosequencing, and qRT-PCR. Additionally, we performed transcription factor binding analysis and identified a number of transcription factors whose binding to the differentially methylated sites or region may contribute to obesity.
These results demonstrate that obesity alters the epigenome through DNA methylation and highlights novel transcriptomic changes in SORBS3 in skeletal muscle.
肥胖是一种由环境和遗传因素引起的代谢性疾病。然而,肥胖的表观遗传机制尚未完全明确。我们研究的目的是探讨骨骼肌DNA甲基化与肥胖中转录组变化相结合所起的作用。
从瘦体重(n = 12;BMI = 23.4 ± 0.7 kg/m²)和肥胖(n = 10;BMI = 32.9 ± 0.7 kg/m²)参与者身上获取基础肌肉活检样本,并结合正常血糖 - 高胰岛素钳夹试验来评估胰岛素敏感性。我们对从股外侧肌活检样本中分离出的DNA和RNA进行了简化代表性亚硫酸氢盐测序(RRBS)下一代甲基化和微阵列分析。在肥胖组与瘦体重组的分析中,启动子区域以及非翻译区(5'和3'UTR)中有13,130个差异甲基化胞嘧啶(DMC;未校正P < 0.05)发生了改变。微阵列分析显示有99个探针有显著变化(校正P < 0.05)。其中,12个基因(包含22个甲基化位点)在基因表达与DNA甲基化之间呈现负相关。具体而言,编码衔接蛋白vinculin的含sorbin和SH3结构域蛋白3(SORBS3)基因表达显著降低(倍数变化为 -1.9),并且在肥胖状态下有9个DMC的甲基化显著增加(甲基化差异范围为5.0%至24.4%)。此外,差异甲基化区域(DMR)分析确定了SORBS3基因5'UTR区域(Chr.8:22,423,530 - 22,423,569)在肥胖组中甲基化增加了11.2%。通过位点特异性测序方法、焦磷酸测序和qRT - PCR验证了SORBS3基因DNA甲基化与基因表达之间的负相关关系。此外,我们进行了转录因子结合分析,并确定了一些转录因子,其与差异甲基化位点或区域的结合可能与肥胖有关。
这些结果表明肥胖通过DNA甲基化改变表观基因组,并突出了骨骼肌中SORBS3基因新的转录组变化。